Trial intelligence / Profile preview

Continuous infusion versus intermittent bolus fentanyl during general anesthesia

TCTR20260910012Phase 4Completed

Sponsor
Department of Anesthesiology and Intensive Therapy, Faculty of Medicine, Universitas Sumatera Utara
Start
Mar 2026
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of fentanyl in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Department of Anesthesiology and Intensive Therapy, Faculty of Medicine, Universitas Sumatera Utara. Primary endpoints: Post-anesthesia recovery time and Early postoperative nausea and vomiting. Started Mar 2026; status: completed.

02

Drugs

fentanyl
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on TCTR20260910012.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20260910012.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call